Page last updated: 2024-10-15

lhrh, n-ac-naphthyl(1)-(4-cl-phe)(2)-trp(3)-arg(6)-ala(10)-

Description

LHRH, N-Ac-naphthyl(1)-(4-Cl-Phe)(2)-Trp(3)-Arg(6)-Ala(10)-: RN given refers to the all (D)-isomer; gonadorelin antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16131287
MeSH IDM0168126

Synonyms (8)

Synonym
1-n-ac-naphthyl-2-(4-cl-phe)-3-trp-6-arg-10-ala-lhrh
lhrh-nptaa
lhrh, n-acetylnaphthyl(1)-4-chlorophenylalanyl(2)-tryptophyl(3)-arginyl(6)-alanine(10)-
lhrh, n-ac-naphthyl(1)-(4-cl-phe)(2)-trp(3)-arg(6)-ala(10)-
d-alaninamide, n-acetyl-3-(1-naphthalenyl)-d-alanyl-4-chloro-d-phenylalanyl-d-tryptophyl-l-seryl-l-tyrosyl-d-arginyl-l-leucyl-l-arginyl-l-prolyl-
gnrh, n-ac-naphthyl(1)-(4-cl-phe)(2)-trp(3)-arg(6)-ala(10)-
86044-78-2
DTXSID30235363
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's5 (71.43)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]